Clinical Trials on Zika Virus Infection in United States

Total 21134 results

Gilead Sciences

Completed

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Respiratory Syncytial Virus Infection

United States, France, Sweden, Korea, Republic of, Switzerland
ViiV Healthcare

Completed

Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment

HIV Infections | Infection, Human Immunodeficiency Virus

United States
University of Texas Southwestern Medical Center

Completed

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

COVID-19 | Respiratory Viral Infection | Antiviral Treatment

United States
Michigan State University
Johns Hopkins University; National Cancer Institute (NCI)

Active, not recruiting

Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva

SARS-CoV2 Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Surveillance of Individuals Following SARS-CoV-2 Infection

COVID-19

United States
HDT Bio
Kaiser Permanente; Rainier Clinical Research Center; C3 Research Associates

Active, not recruiting

Safety And Immunogenicity Of HDT-301 Targeting A SARS-CoV-2 Variant Spike Protein

SARS-CoV2 Infection

United States
Schiano, Thomas D., MD
iTherX Pharmaceuticals Inc.

Terminated

Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection

Hepatitis C Infection

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Phase 1 Study of SAR440894 vs Placebo

Chikungunya Virus Infection

United States
ProgenaBiome
Big Corona Ltd.

Withdrawn

A Study of Combination Therapies to Treat COVID-19 Infection

COVID-19 | Coronavirus Infection | SARS-CoV 2 | COVID | Corona Virus Infection | SARS Pneumonia | Coronavirus-19 | Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults

Human Papillomavirus Infection | Human Papillomavirus-Related Carcinoma

United States
National Institute on Drug Abuse (NIDA)

Completed

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals (MAP)

HIV Infections | HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

HIV Infection

United States
Fred Hutchinson Cancer Center
University of Washington

Completed

MMF for HIV Reservoir Reduction

Human Immunodeficiency Virus I Infection

United States
ViiV Healthcare
GlaxoSmithKline

Terminated

A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176

Infection, Human Immunodeficiency Virus

United States
GlaxoSmithKline

Completed

Single and Repeated Dose Escalation Study of GSK2838232

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

Dolutegravir Renal Impairment Study

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare
GlaxoSmithKline; Shionogi

Completed

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Infection, Human Immunodeficiency Virus

United States
GlaxoSmithKline

Completed

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Healthy Subjects | Infection, Human Immunodeficiency Virus

United States
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection

Hepatitis C Virus

United States
Inovio Pharmaceuticals

Completed

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Papillomavirus Infections

United States, Puerto Rico
MedMira Laboratories Inc.

Withdrawn

Rapid Diagnostics for HIV and Hepatitis

HIV Infections | Hepatitis B Infections | Hepatitis C Infections

United States
Montreal Heart Institute
National Heart, Lung, and Blood Institute (NHLBI); Bill and Melinda Gates Foundation and other collaborators

Terminated

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (COVID-19)

Corona Virus Infection

Spain, United States, Canada, Brazil, Greece, South Africa
University of North Carolina, Chapel Hill
Colgate Palmolive

Terminated

Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 (COL)

Coronavirus Infection | COVID19 | SARS CoV-2 Infection

United States
AIDAR Health, Inc.
MAXIS, LLC

Withdrawn

AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation (AIDI)

Sars-CoV-2 Infection

United States
Stanford University
Pfizer

Completed

Paxlovid for Treatment of Long Covid (STOP-PASC)

Long COVID | Post-acute Sequelae of SARS-CoV-2 Infection

United States
ViiV Healthcare
GlaxoSmithKline

Completed

Drug-drug Interaction (DDI) Rifabutin

Infection, Human Immunodeficiency Virus

United States
GlaxoSmithKline

Completed

GSK706769 Repeat Dose Study

Infection, Human Immunodeficiency Virus

United States
ViiV Healthcare

Completed

A Study of the Relative Bioavailability of BMS-626529 Administered as BMS-663068 From 150mg Low-dose Extended-release Tablets Compared to 600mg Reference Extended-release Tablets in Healthy Subjects

Infection, Human Immunodeficiency Virus

United States
Columbia University

Recruiting

Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence (C-PIC)

COVID-19 | SARS-CoV 2 | Corona Virus Infection

United States
University of South Alabama

Terminated

Trial of Hydroxychloroquine In Covid-19 Kinetics (THICK)

Corona Virus Infection | Covid 19

United States
National Institute of Diabetes and Digestive and...

Completed

Genetics of Hepatitis C Virus Infection

Hepatitis C | Liver Disease

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Herpes Zoster

United States
University of North Carolina, Chapel Hill

Recruiting

Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2) (MOR2)

COVID-19 | Coronavirus Infection | SARS CoV 2 Infection

United States
Sky Medical Supplies & Equipments, LLC

Recruiting

This Trial is a Clinical Performance Validation Study That Will Evaluate the Clinical Agreement of the Sky Medical™ Rapid Antigen Test Comparing the Antigen Rapid Test to RT-PCR

COVID-19 | Sars-CoV-2 Infection

United States
University of Arizona

Recruiting

Exercise and COVID-19 Viral T-cell Immunity (VIC)

Influenza | COVID-19 Respiratory Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

Herpes Zoster

United States, Puerto Rico
Icahn School of Medicine at Mount Sinai

Recruiting

The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection

HIV Infection

United States
Hennepin Healthcare Research Institute
American Heart Association

Completed

Cardiovascular Prevention for Persons With HIV

HIV Infection | Cardiovascular Disease Risk

United States
National Institute of Allergy and Infectious Diseases...

Completed

Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist

Acquired Immunodeficiency Syndrome | HIV Infection

United States
National Cancer Institute (NCI)

Completed

Combination Drug Treatment of Pediatric HIV Infection

HIV Infection

United States
National Cancer Institute (NCI)

Completed

Capravirine to Treat Children With HIV Infection

HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model

Influenza Infection

United States
Imperial College London

Completed

Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

Liver Fibrosis

United Kingdom
Medicago

Completed

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

United States
Inova Health Care Services

Completed

Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant.

Influenza, Human | Transplantation Infection

United States
University of Southern California

Completed

Nanopulse Efficacy Study for the Treatment of Common Warts

Common Warts

United States

Clinical Trials on Zika Virus Infection in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations